Quantcast

Latest End Stage Renal Disease Stories

2011-04-28 07:00:00

LAWRENCE, Mass., April 28, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today commented on study results presented by the Chronic Disease Research Group (CDRG) showing daily home hemodialysis with the NxStage System One is associated with reduced mortality and higher survival estimates for patients when compared with conventional thrice-weekly therapy. The retrospective cohort study examines the mortality and three-year...

2011-04-11 21:59:20

Combining the chronic kidney disease markers of creatinine-based estimated glomerular filtration rate and urine albumin-to-creatinine ratio with the biomarker cystatin C was associated with improved prediction of end-stage kidney disease and all-cause death, according to a study that will appear in the April 20 issue of JAMA. The study is being published early online to coincide with its presentation at the World Congress of Nephrology. Chronic kidney disease (CKD) is currently defined as...

2011-04-01 16:57:00

WASHINGTON, April 1, 2011 /PRNewswire-USNewswire/ -- Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, commends the Centers for Medicare and Medicaid Services (CMS) for eliminating the so-called "transition adjustment" imposed on dialysis facilities as part of the new Medicare end-stage renal disease (ESRD) prospective payment system (PPS). Last year, in finalizing rules on the new ESRD PPS, CMS estimated the...

2011-03-07 07:30:00

NEW YORK, March 7, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals (Nasdaq: KERX) today announced that the final dataset from the Phase 3 short-term clinical trial of Zerenex(TM) (ferric citrate) for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis has been selected for oral presentation at the upcoming National Kidney Foundation (NKF) Spring Clinical Meetings, to be held April 26-30, 2011 in Las Vegas, Nevada. The Zerenex data will be presented by David...

2011-02-20 17:04:00

LAWRENCE, Mass. and PHOENIX, Feb. 20, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits, significant improvement in overall sleep quality and a marked improvement in Restless Legs Syndrome (RLS) symptoms experienced by patients after 12 months of daily home hemodialysis with...

2011-01-19 14:29:00

WASHINGTON, Jan. 19, 2011 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP), an alliance of patient advocates, dialysis professionals, providers and manufacturers working together to improve the quality of care for individuals with End Stage Renal Disease (ESRD), named Ron Kuerbitz, Executive Vice President for Fresenius Medical Care-North America, the Coalition's new Chairman for the 2011-2012 term. Taking the helm of KCP, the nation's leading voice for the kidney care community,...

2010-12-16 06:30:00

LAWRENCE, Mass., Dec. 16, 2010 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their seven-year anniversary of home hemodialysis treatment with the NxStage® System One(TM), the only hemodialysis machine cleared by the FDA for home use. Each of these patients continues to experience the improved health and quality of life benefits possible with...

2010-11-30 06:30:00

LAWRENCE, Mass., Nov. 30, 2010 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems division has started distributing its in-center products through Metro Medical Supply, Inc., a leading full-service dialysis supplies provider. NxStage has given Metro Medical non-exclusive distribution rights to Medisystems' products, including its premier bloodline, Streamline® and its...

2010-11-30 05:00:00

NEW YORK, Nov. 30, 2010 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced positive top-line results from the Phase 3 short-term efficacy study component of its Phase 3 registration program of Zerenex(TM) (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis. In this study, conducted pursuant to a Special...

2010-11-22 13:23:03

Variant MYH9 gene is found in 55 percent of black patients in kidney disease study In African Americans with kidney disease related to hypertension (high blood pressure), a common gene variant is associated with a sharply increased risk of progressive kidney disease, according to a study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition. End Stage Renal Disease (ESRD) associated with hypertension occurs in the African American population at a rate...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.